Antimicrobial activity of phenolic acids against commensal, probiotic and pathogenic bacteria.
Phenolic acids (benzoic, phenylacetic and phenylpropionic acids) are the most abundant phenolic structures found in fecal water. As an approach towards the exploration of their action in the gut, this paper reports the antimicrobial activity of thirteen phenolic acids towards Escherichia coli, Lactobacillus spp., Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans. The growth of E. coli ATCC 25922 was inhibited by only four of the phenolic acids tested at a concentration of 1000 microg/mL, whereas pathogenic E. coli O157:H7 (CECT 5947) was susceptible to ten of them. The genetically manipulated E. coli lpxC/tolC strain was highly susceptible to phenolic acids. The growth of lactobacilli (Lactobacillus paraplantarum LCH7, Lactobacillus plantarum LCH17, Lactobacillus fermentum LPH1, L. fermentum CECT 5716, Lactobacillus brevis LCH23, and Lactobacillus coryniformis CECT 5711) and pathogens (S. aureus EP167 and C. albicans MY1055) was also inhibited by phenolic acids, but to varying extents. Only P. aeruginosa PAO1 was not susceptible to any of the phenolic compounds tested. Structure-activity relationships of phenolic acids and some of their diet precursors [(+)-catechin and (-)-epicatechin] were established, based on multivariate analysis of microbial activities. The antimicrobial properties of phenolic acids reported in this paper might be relevant in vivo.
Cueva
Carolina
C
Instituto de Fermentaciones Industriales/CIAL (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain.
Moreno-Arribas
M Victoria
MV
Martín-Alvarez
Pedro J
PJ
Bills
Gerald
G
Vicente
M Francisca
MF
Basilio
Angela
A
Rivas
Concepción López
CL
Requena
Teresa
T
Rodríguez
Juan M
JM
Bartolomé
Begoña
B
D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology*; D001565:Benzoates / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects; D024881:Drug Resistance, Bacterial; D025141:Drug Resistance, Fungal; D004926:Escherichia coli / Q000187:drug effects; D006090:Gram-Negative Bacteria / Q000187:drug effects* / Q000254:growth & development; D006094:Gram-Positive Bacteria / Q000187:drug effects* / Q000254:growth & development; D006801:Humans; D062385:Hydroxybenzoates / Q000737:chemistry / Q000494:pharmacology; D007422:Intestines / Q000382:microbiology; D007778:Lactobacillus / Q000187:drug effects; D010648:Phenylacetates / Q000494:pharmacology*; D010666:Phenylpropionates / Q000494:pharmacology*; D019936:Probiotics; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013211:Staphylococcus aureus / Q000187:drug effects; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D001565:Benzoates; D062385:Hydroxybenzoates; D010648:Phenylacetates; D010666:Phenylpropionates; C017616:phenolic acid